RecallDepth
Class II Terminated

Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-4699-30; b) 50 mL Single patient infusion vial, 500 mg/50 mL (10 mg/mL), NDC 0409-4699-33; c) 100 mL Single patient infusion vial, 1 g/100 mL (10 mg/mL), NDC 0409-4699-24; Rx only, Hospira, Inc., Lake Forest, IL 60045 USA

This recall has been terminated (originally issued February 20, 2013).

Company
Hospira Inc.
Recall Initiated
November 15, 2012
Posted
February 20, 2013
Recall Number
D-159-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
273,925 vials
Firm Location
Lake Forest, IL, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter: Visible particulate and particulate embedded in vials were observed during retain inspection.

Distribution

Nationwide

Lot / Code Info

Lot #: a) 95-070-DJ, Exp 11/01/12; 04-584-DJ, 04-652-DJ, Exp 04/01/13; 05-718-DJ, Exp 05/01/13; 06-815-DJ, Exp 06/01/13; b) 04-525-DJ, 04-530-DJ, 04-641-DJ-04-646-DJ, Exp 04/01/13; c) 02-291-DJ, Exp 02/01/13; 05-725-DJ, 05-732-DJ, Exp 05/01/13; 07-925-DJ, Exp 07/01/13; 09-065-DJ, Exp 09/01/13; 10-129-DJ, 10-133-DJ, 10-148-DJ, Exp 10/01/13, Note lot number may be followed by 01.

More recalls by Hospira Inc.

View all recalls by this company →

Other recent Class II Drug recalls